Mustang Bio, Inc. (MBIO) stock
MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.38−0.01 (-2.56%)
Close on Nov 18, 2026Market cap $2.88MP/E –Yield –
Mustang Bio operating margin
Operating margin is operating income as a percentage of revenue.
Mustang Bio's operating margin for the twelve months ending Sep 30, 2018 was -70206.0%.
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2018 | Mar 31, 2018 | -12954.0% | – |
See a number that looks wrong?